NCT03315065View on ClinicalTrials.gov

19F Thoracic Radiotherapy for Lung Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 16, 2018

Primary Completion Date

June 25, 2019

Study Completion Date

June 25, 2019

Conditions
Lung Cancer
Interventions
DRUG

Perfluorinated Gas/Oxygen Mixture

19-Fluorine (19F) MRI of the lungs with 21%/79% Oxygen/Perfluorinated Gas, ≤ 25 liters, gas and Mixture of 30% perfluoropropane and 70% oxygen to measure perfusion single visit, \< 1 hour

Trial Locations (1)

27705

Duke University Medical Center - Cancer Center, Durham

All Listed Sponsors
lead

Hal C Charles

OTHER

NCT03315065 - 19F Thoracic Radiotherapy for Lung Cancer | Biotech Hunter | Biotech Hunter